With the advent of genome-wide association studies, several polymorphisms in circadian clock and clock-controlled genes have been discovered to be associated with increased susceptibility to metabolic diseases including both T2D and obesity [4,5,6,7,8,9,10,11]. This evidence concerns the gene CLOCK and metabolic disease.